Tonghua Dongbao Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Tonghua Dongbao Pharmaceutical has a total shareholder equity of CN¥6.5B and total debt of CN¥359.0M, which brings its debt-to-equity ratio to 5.5%. Its total assets and total liabilities are CN¥7.0B and CN¥548.3M respectively. Tonghua Dongbao Pharmaceutical's EBIT is CN¥713.9M making its interest coverage ratio -6.6. It has cash and short-term investments of CN¥512.4M.
Key information
5.5%
Debt to equity ratio
CN¥359.00m
Debt
| Interest coverage ratio | -6.6x |
| Cash | CN¥512.40m |
| Equity | CN¥6.50b |
| Total liabilities | CN¥548.27m |
| Total assets | CN¥7.04b |
Recent financial health updates
Recent updates
Some May Be Optimistic About Tonghua Dongbao Pharmaceutical's (SHSE:600867) Earnings
Sep 06
Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Analysts Just Slashed This Year's Estimates
Sep 05Calculating The Intrinsic Value Of Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867)
Aug 22Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet
Jun 19Improved Earnings Required Before Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Shares Find Their Feet
May 23Financial Position Analysis
Short Term Liabilities: 600867's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥406.8M).
Long Term Liabilities: 600867's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥141.5M).
Debt to Equity History and Analysis
Debt Level: 600867 has more cash than its total debt.
Reducing Debt: 600867's debt to equity ratio has reduced from 11.4% to 5.5% over the past 5 years.
Debt Coverage: 600867's debt is well covered by operating cash flow (185.9%).
Interest Coverage: 600867 earns more interest than it pays, so coverage of interest payments is not a concern.